Table 1.
Participant characteristicsa
| Healthy group (n = 16) | Combined HD patients (n = 31) | P-value | Exercising HD patients (n = 16) | Non-exercising HD patients (n = 15) | P-value | |
|---|---|---|---|---|---|---|
| Age (years) | 61.5 ± 10.9 | 63.4 ± 13.7 | 0.63 | 57.0 ± 10.5 | 70.2 ± 13.7 | 0.005* |
| Gender (male/female) | 8/8 | 18/13 | 0.37 | 8/8 | 10/5 | 0.35 |
| Weight (kg) | 75.3 ± 16.6 | 75.9 ± 23.1 | 0.92 | 71.0 ± 24.9 | 81.2 ± 20.6 | 0.23 |
| BMI (kg/m2) | 26.1 ± 5.0 | 27.1 ± 6.4 | 0.58 | 25.9 ± 6.7 | 28.4 ± 6.1 | 0.29 |
| Systolic blood pressure (mmHg) | 129 ± 13 | 136 ± 21 | 0.16 | 135 ± 24 | 138 ± 19 | 0.68 |
| eGFR (mL/min/1.73 m2) | 102 ± 22 | b | – | b | b | – |
| Number of comorbidities | – | – | – | 4 ± 2 | 4 ± 2 | 0.57 |
a
Data are presented as mean ± standard deviation.
b
All HD patients had established end-stage renal disease and had received HD treatment for at least 3 months.
*
Denotes a significant difference between exercising HD patient and non-exercising HD patient groups.